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S U M M A R Y
Objective: To investigate the role of the neutrophil Fcg receptor I (CD64) index in the diagnosis of
spontaneous bacterial peritonitis (SBP) in cirrhotic patients.
Methods: A total of 123 cirrhotic patients with ascites who fulﬁlled the inclusion criteria were enrolled in
this study. Ascites and blood samples were collected; the polymorphonuclear neutrophil (PMN) count,
bacterial culture, and related laboratory tests were performed. The CD64 index was determined for each
sample using ﬂow cytometry.
Results: The neutrophil CD64 index results were signiﬁcantly higher in cirrhotic patients with SBP than
in those without SBP (p < 0.001). There was a positive correlation between the neutrophil CD64 index
and the PMN count in ascites. In the receiver operating characteristic curve (ROC) analysis, the area
under the curve (AUC) was 0.894 (95% conﬁdence interval 0.823–0.964, p < 0.001). The optimal cut-off
value for the neutrophil CD64 index was 2.02. The sensitivity and speciﬁcity of the neutrophil CD64
index for cirrhotic patients with SBP were 80.49% and 93.90%, respectively. The elevated neutrophil CD64
index was down-regulated by antibiotic therapy (p = 0.002).
Conclusions: The neutrophil CD64 index could be used as a sensitive and speciﬁc indicator for the
diagnosis of SBP in cirrhotic patients with ascites and is also modulated by antibiotic therapy.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Spontaneous bacterial peritonitis (SBP) is a common and
serious complication in patients with ascites caused by decom-
pensated liver cirrhosis, with an incidence of 10% to 30%.1 Most
cases are caused by bacterial infections spreading to the
peritoneum across the gut wall or mesenteric lymphatics, or less
frequently from hematogenous transmission, in combination with
an impaired immune system and in the absence of an identiﬁed
intra-abdominal source of infection or malignancy.2
The development of ascites in cirrhosis indicates a poor
prognosis, with a mortality rate of approximately 40% in the ﬁrst
year after diagnosis and 50% in the second year; there is an
increased risk of other liver complications, including refractory
ascites, SBP, hyponatremia, and hepatorenal syndrome (HRS).3* Corresponding author. Tel.: +86-13718641405; fax: +010-63054847.
E-mail address: loujinli@163.com (J. Lou).
http://dx.doi.org/10.1016/j.ijid.2016.06.021
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Studies have shown that some symptoms of SBP patients may be
masked by the symptoms of liver cirrhosis and the effects of
medication.1 A weak response to inﬂammatory stimulation in
patients with liver cirrhosis due to hypoimmunity and large
amounts of ascites cause atypical abdominal signs and a less
obvious rise in body temperature; therefore, the diagnosis of SBP
by symptoms and signs is clinically insufﬁcient .
Although the mortality of SBP has decreased from 90% to 20% in
recent years due to the use of antibiotics, the mortality in
untreated patients remains as high as 50%.4,5 On the other hand,
the empirical use of antibiotics in the clinical setting is a normal
way to alleviate the condition of patients with ascites. The misuse
of antibiotics causes drug resistance and has an adverse effect on
the efﬁcacy of long-term treatments. Therefore, the early and
effective diagnosis of SBP, along with the prompt initiation of
empiric antibiotic therapy, has been considered crucial to overall
patient survival.6
Although a diagnostic paracentesis and appropriate ascitic ﬂuid
analysis is considered essential for all patients admitted withciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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such as bleeding and infection.7 Meanwhile, in the emergency
setting, performing ascitic ﬂuid culture examinations is time-
consuming and not always possible. Hence, according to the
current guidelines, a diagnosis of SBP is made when the ascitic ﬂuid
polymorphonuclear neutrophil (PMN) count is 0.25  109 cells/l
. However, the dissociation of PMNs during transportation to the
laboratory may lead to false-negative results. Furthermore, a large
amount of ascitic ﬂuid in cirrhotic patients and the many visible
components in ascitic ﬂuid could make cell counts inaccurate.
Manual measurement of the ascitic ﬂuid PMN count is operator-
dependent, making quality control difﬁcult, and can delay the
diagnosis.8,9
In this regard, a new inﬂammatory marker that could predict
bacterial infections in ascitic ﬂuid and assist in determining the
effect of therapy would be extremely useful. In recent years, several
studies on Fcg receptor I (FcgRI), otherwise named CD64, have
conﬁrmed this to be a marker of infection. In resting neutrophils,
CD64 is expressed at a very low level (approximately 1400 receptors
per cell on average). However, the up-regulation of CD64 on the
surface of neutrophils is induced by inﬂammatory cytokines such as
interferon gamma10 and granulocyte colony-stimulating factor,11
which are produced during bacterial infections. Therefore, the
expression of CD64 on human neutrophils may be used as an
improved test for the early diagnosis of bacterial infections.
Recently, the neutrophil CD64 index – a novel indicator – has been
conﬁrmed to be efﬁcient in predicting sepsis,12,13 neonatal
infection,14,15 intestinal diseases,16 surgical infection,17 etc.
Appropriate diagnostic studies are required to identify infec-
tions of the ascitic ﬂuid in cirrhotic patients. On account of the
rapid and valid application of the neutrophil CD64 index to
indicate bacterial infections, the aim of the present study was to
investigate the role of the CD64 index in the diagnosis of SBP in
cirrhotic patients.
2. Materials and methods
2.1. Study population
This was a prospective study conducted at Beijing You’an
Hospital, Capital Medical University, China, from March 2014 to
June 2015. A total of 123 patients with ascites caused by cirrhosis
who fulﬁlled the inclusion criteria were enrolled in the study. TheCD64 index ¼ ðneutrophil CD64 average fluorescence intensity=lymphocyte CD64 average fluorescence intensityÞðmonocyte CD64 average fluorescence intensity=neutrophil CD64 average fluorescence intensityÞinclusion criteria were as follows: (1) age 18 years; (2) diagnosis
of liver cirrhosis according to clinical, liver tissue pathology,
biochemical, and imaging markers; (3) presence of ascites. The
exclusion criteria were the following: (1) secondary peritonitis; (2)
tuberculous peritonitis; (3) other infections except ascites infec-
tion; (4) use of immunosuppressants or other chemotherapy
drugs; (5) trauma, surgery, or other vital disease except liver
disease within 3 months of study entry; (6) cancers other than liver
cancer. Twenty healthy subjects were also enrolled.
2.2. Diagnostic criteria for SBP
The diagnosis of SBP was based on two of the following criteria
from available guidelines:18,19 (1) abdominal pain and/or hyper-
thermia, and/or abdominal and rebound tenderness (excluding
secondary peritonitis); (2) ascitic ﬂuid PMN count 0.25  109/l;
(3) positive ascitic ﬂuid bacterial culture. The non-SBP groupincluded patients with ascites caused by cirrhosis without SBP; the
SBP group included patients with cirrhosis who had SBP.
2.3. Paracentesis and ascitic ﬂuid culture
Diagnostic paracentesis was carried out at the bedside
using a sterile method before antibiotic therapy. The aspirated
ascitic ﬂuid was collected in ethylenediaminetetraacetic acid
(EDTA) tubes and analyzed within 3 h of aspiration. The ascitic
ﬂuid total and differential cell counts were performed using
an optical microscope (CX41; Olympus, Japan). Bacterial
cultures were obtained by bedside inoculation of 20 ml of
ascitic ﬂuid into aerobic and anaerobic bottles (BACTEC 9120;
BD, USA). The bottles were incubated at 35 8C for 3 days and if it
was negative, it would be discarded. Bacterial identiﬁcation and
antimicrobial susceptibility testing were performed using an
automated microbial identiﬁcation system (Phoenix 100; BD,
USA).
2.4. Patient assessments
Relevant tests were performed on blood samples to assess the
condition of the patient. The peripheral white blood cell (WBC) and
platelet (PLT) counts were obtained using an automated blood cell
analyzer (XT-4000i; Sysmex, Japan). Liver and renal biochemical
parameters, such as alanine aminotransferase (ALT), aspartate
aminotransferase (AST), total bilirubin, albumin, blood urea
nitrogen, and creatinine levels, were obtained using an automated
biochemical analyzer (Au5400; Olympus, Japan).
2.5. Neutrophil CD64 index
Blood samples were collected within 6 h after paracentesis
and before antibiotic therapy; they were processed within 24 h
after collection for the measurement of CD64 expression on
leukocytes by ﬂow cytometry (FACSCalibur; BD, USA) using a
CD14/CD64 assay kit (BD, USA). The kit includes ﬂuorescein
isothiocyanate (FITC)-conjugated anti-CD14 and phycoerythrin
(PE)-conjugated anti-CD64 antibodies. The lymphocyte, mono-
cyte, and neutrophil populations are deﬁned by their forward
and side scatter characteristics along with surface CD14
staining. The CD64 index was calculated using the following
formula:CD64 expression on lymphocytes served as an internal negative
control, while CD64 expression on monocytes served as an
internal positive control.
2.6. Statistical analysis
Data were entered into a database and analyzed using SPSS
version 16.0 software (SPSS Inc., Chicago, IL, USA). Data are
expressed as the number (%), mean  standard error of the mean
(SEM), median (interquartile range, IQR), or area under the receiver
operating characteristic curve (AUC) with the 95% conﬁdence interval
(CI), where appropriate. The t-test was used for quantitative variables
subordinate to the normal distribution, and the Mann–Whitney U-
test was used for the comparison of quantitative variables with a non-
normal distribution. The correlation of the neutrophil CD64 index
with the WBC and PMN counts in ascites samples was assessed using
the Spearman test. Receiver operating characteristic (ROC) curves
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optimum cut-off value by maximizing the sensitivity and speciﬁcity.
A p-value of < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Clinical and laboratory characteristics of patients
A total of 123 cirrhotic patients with ascites were enrolled in
the study, including 41 patients with clinical SBP (ascitic ﬂuid
PMN count 0.25  109/l or positive ascitic ﬂuid bacterial
culture) and 82 patients without SBP (ascitic ﬂuid PMN
count < 0.25  109/l and negative ascitic ﬂuid bacterial culture).
The etiologies of liver cirrhosis were determined by laboratory
tests and clinical diagnosis. Cirrhosis was related to hepatitis B
alone in 59% (n = 73) of the patients, hepatitis C alone in 5%
(n = 6), alcoholism alone in 18% (n = 22), cholestasis alone in 3%
(n = 4), and a combination of multiple factors in 5% (n = 6). The
cause of the cirrhosis was unknown in 10% (n = 12) of the
patients. The average age of the subjects was 55.13  1.31 years
in the SBP patient group and 54.36  1.64 years in the non-SBP
patient group.
There were no signiﬁcant differences in age, PLT count, ALT,
AST, albumin, gamma-glutamyltransferase, alkaline phosphatase,
total bile acid, creatinine, or urea between the two patient groups
(p > 0.05). There were differences between the groups in
prothrombin time, international normalized ratio (INR), total
bilirubin, total protein, and cholinesterase. The WBC count in the
blood was signiﬁcantly higher in SBP patients than in non-SBP
patients (p < 0.001). All the clinical and laboratory characteristics
of the cirrhotic patients are shown in Table 1.Table 1
Clinical and laboratory characteristics of cirrhotic patients with and without
spontaneous bacterial peritonitis; results are presented as the mean  SEM, median
(IQR), or n (%)
SBP (n = 41) non-SBP (n = 82) p-Value
Sex, female/male 27/14 65/17 0.106
Age, years 54.36  1.64 55.13  1.31 0.726
Etiology 0.204
HBV 28 (68.30%) 45 (54.93%) -
Alcoholism 5 (12.19%) 17 (19.72%) -
HCV 1 (2.44%) 5 (7.04%) -
Cholestasis 1 (2.44%) 3 (2.82%) -
Multiple 0 (0%) 6 (8.45%) -
Unknown 6 (14.63%) 6 (7.04%) -
Laboratory tests
PLT (109/l) 108 (80–179) 88 (54–142) 0.073
PT (s) 17.8 (15.6–22.6) 14.3 (12.6–18.5) <0.001
INR 1.57 (1.38–1.98) 1.27 (1.13–1.60) <0.001
ALT (U/l) 32.3 (16.9–55.13) 29.2 (17.6–50.3) 0.699
AST (U/l) 67.9 (35.9–129.4) 63.6 (34.5–103.9) 0.679
Tbil (mmol/l) 79.5 (32.3–152.2) 45.7 (24.1–96.7) 0.029
TP (g/l) 52.6 (45.6–59.1) 56.9 (51.3–63.9) 0.037
ALB (g/l) 28.5 (25.1–30.5) 29.4 (26.7–32.3) 0.087
GGT (U/l) 73.0 (34.8–164.9) 74.3 (36.5–198.3) 0.662
ALP (U/l) 106.8 (68.5–208.9) 99.4 (70.4–157.8) 0.479
TBA (mmol/l) 36.5 (13.6–109.3) 35.0 (16.4–79.5) 0.394
CHE (U/l) 1125 (761–1594) 1641 (1217–2228) 0.005
Urea (mmol/l) 8.92 (5.37–19.58) 6.85 (4.66–11.55) 0.063
Creatinine (mmol/l) 85.4 (60.1–193.9) 78.75 (57.40–110.75) 0.251
WBC (109/l) 11.18 (6.715–15.215) 4.88 (3.58–7.31) <0.001
ALB, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CHE, cholinesterase; GGT, gamma-glutamyltransfer-
ase; HBV, hepatitis B virus; HCV, hepatitis C virus; INR, international normalized
ratio; IQR, interquartile range; PLT, platelets; PT, prothrombin time; SBP,
spontaneous bacterial peritonitis; SEM, standard error of the mean; TBA, total
bile acid; Tbil, total bilirubin; TP, total protein; WBC, white blood cell count.3.2. Detection of ascitic ﬂuid in cirrhotic patients
Ascites is a common complication in cirrhotic patients and
ascites infection results in a poor prognosis. Although the diagnosis
of SBP relies on the PMN count, microbial culture is the most
reliable criterion for all kinds of infection. Patient ascitic ﬂuid
samples were collected and cultured both aerobically and
anaerobically for 3 days. Thirteen of 41 patients diagnosed
clinically with SBP had positive ascites cultures, a positive rate
of 31.71%. Nine different types of bacteria were cultured in the
ascites of these 13 patients: Escherichia coli (n = 4, 31.7%), Klebsiella
pneumoniae (n = 2, 15.4%), Staphylococcus aureus (n = 1, 7.7%),
Enterococcus faecalis (n = 1, 7.7%), Enterobacter cloacae (n = 1, 7.7%),
Acinetobacter baumannii (n = 1, 7.7%), Enterococcus faecium (n = 1,
7.7%), Staphylococcus epidermidis (n = 1, 7.7%), and Stenotrophomo-
nas maltophilia (n = 1, 7.7%). This shows that the diagnosis of
infection in ascites cannot rely on bacterial culture alone on
account of the low positive rate.
Meanwhile, using the diagnostic criteria of SBP, cells were
detected in the ascites samples of cirrhotic patients. It was found
that the WBC and PMN counts in the ascites of SBP patients
(median 1.778, IQR 0.927–6.079 and median 1.352, IQR 0.432–
4.267) were both signiﬁcantly higher than those in non-SBP
patients (median 0.172, IQR 0.107–0.285 and median 0.026, IQR
0.016–0.052) (p < 0.001).
3.3. Neutrophil CD64 index in SBP patients
Since diagnostic paracentesis is an invasive detection method, a
minimally traumatic method to identify ascites infection effec-
tively was sought. In this study, the difference in neutrophil CD64
index was explored in SBP patients, non-SBP patients, and healthy
subjects.
A signiﬁcant difference was found among the three groups
(p < 0.001). The neutrophil CD64 index in SBP samples (median
6.09, IQR 2.35–15.23) was signiﬁcantly higher than that in non-SBP
samples (median 0.71, IQR 0.36–1.05; p < 0.001) and that in
healthy subjects (median 0.63, IQR 0.08–1.41; p < 0.001). Howev-
er, there was no signiﬁcant difference between cirrhotic patients
without SBP and healthy subjects (p = 0.511) (Figure 1). Neutrophil
CD64 expression in the three groups is shown in Figure 2.
A tendency towards a higher neutrophil CD64 index was
witnessed in culture-positive SBP patients (16.53  4.06) compared
with culture-negative SBP patients (8.87  2.21) in the experimentFigure 1. Neutrophil CD64 index in healthy subjects, cirrhotic patients without SBP,
and cirrhotic patients with SBP. The neutrophil CD64 index in SBP samples (median
6.09, IQR 2.35–15.23) was signiﬁcantly higher than that in non-SBP samples
(median 0.71, IQR 0.36–1.05; p < 0.001) and that in healthy subjects (median 0.63,
IQR 0.08–1.41; p < 0.001). However, there was no signiﬁcant difference between
cirrhotic patients without SBP and healthy people (p = 0.511). (IQR, interquartile
range; SBP, spontaneous bacterial peritonitis.).
Figure 2. Neutrophil CD64 expression in the three groups. Determination of different cells in peripheral blood by double-staining using ﬂuorescein isothiocyanate (FITC)-
conjugated anti-CD14 and phycoerythrin (PE)-conjugated anti-CD64 antibodies. (A) Healthy people. (B) Patients with ascites caused by cirrhosis but without SBP. (C) SBP
patients. (SBP, spontaneous bacterial peritonitis.).
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(Figure 3).
3.4. Correlation of the neutrophil CD64 index and the PMN count in
ascites
Since the main diagnostic criterion of SBP is the PMN count in
ascites, the correlation of the neutrophil CD64 index and the PMN
count in ascites was analyzed in order to conﬁrm that the reason
for up-regulation of the neutrophil CD64 index was ascites
infection.Figure 3. Neutrophil CD64 index in culture-negative SBP and culture-positive SBP
patients. There was no signiﬁcant difference in the neutrophil CD64 index between
culture-negative SBP patients (8.87  2.21) and culture-positive SBP patients
(16.53  4.06) (p = 0.080). (CN, culture-negative; CP, culture-positive; SBP,
spontaneous bacterial peritonitis.).As shown in Figure 4, there was a moderate positive correlation
between the neutrophil CD64 index and the PMN count in ascites
(p < 0.001, r = 0.484), as well as a positive correlation between the
neutrophil CD64 index and the WBC count in ascites (p < 0.001,
r = 0.450). These results indicate that the neutrophil CD64 index in
blood can be regulated by ascites infection.
3.5. Clinical value of the neutrophil CD64 index in diagnosing SBP
A ROC curve was generated and showed that the neutrophil
CD64 index was a valuable parameter for discriminating cirrhotic
patients with SBP from those without SBP. The AUC was 0.894 (95%
CI 0.823–0.964) (p < 0.001) (Figure 5).
Several potential cut-off values that can be considered for the
diagnosis of SBP are presented in Table 2. The optimal cut-off value
for the neutrophil CD64 index, with the highest combined
sensitivity and speciﬁcity to distinguish SBP samples from those
without SBP, was 2.02. At this cut-off level, the sensitivity,
speciﬁcity, and accuracy were 80.49%, 93.90%, and 89.43%,
respectively, while the negative predictive value (NPV) and
positive predictive value (PPV) were 90.58% and 86.84%, respec-
tively.
3.6. The neutrophil CD64 index is modulated by antibiotic therapy
The blood of 10 newly diagnosed SBP patients was analyzed and
the neutrophil CD64 indices were compared before and after 3–5
days of antibiotic therapy. It was found that the neutrophil CD64
index is modulated by antibiotic therapy. The neutrophil CD64
index was elevated in newly diagnosed SBP patients, but this
increased neutrophil CD64 index was signiﬁcantly down-regulated
Figure 4. Correlation of the neutrophil CD64 index and cell counts in ascites. A
signiﬁcant positive correlation was found between the neutrophil CD64 index and
the polymorphonuclear neutrophil cell count (PMN) in ascites (p < 0.001, r = 0.484),
as well as a positive correlation between the neutrophil CD64 index and the white
blood cell count (WBC) in ascites (p < 0.001, r = 0.450).
Figure 5. ROC curve of the neutrophil CD64 index in the diagnosis of SBP. The AUC
was 0.894 (95% CI 0.823–0.964; p < 0.001). The optimal cut-off value for the
neutrophil CD64 index was 2.02. The sensitivity and speciﬁcity of the neutrophil
CD64 index for cirrhotic patients with SBP were 80.49% and 93.90%, respectively.
(AUC, area under the curve; CI, conﬁdence interval; ROC, receiver operating
characteristic; SBP, spontaneous bacterial peritonitis.).
Table 2
Diagnostic accuracy of the neutrophil CD64 index in cirrhosis patients with
spontaneous bacterial peritonitis
Cut-off
value
Sensitivity
(%)
Speciﬁcity
(%)
Accuracy
(%)
PPV
(%)
NPV
(%)
PLR NLR
1.64 80.49 87.80 85.37 76.74 90.00 6.60 0.22
1.84 80.49 91.46 87.80 82.50 90.36 9.43 0.21
2.02 80.49 93.90 89.43 86.84 90.59 13.20 0.20
2.21 78.05 93.90 88.62 86.48 89.53 12.80 0.23
2.48 70.73 93.90 86.18 85.29 86.52 11.60 0.31
NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive
likelihood ratio; PPV, positive predictive value.
Figure 6. The neutrophil CD64 indices of SBP patients when newly diagnosed and
after therapy. The neutrophil CD64 index was elevated in SBP patients at ﬁrst
diagnosis, but this increased neutrophil CD64 index was signiﬁcantly down-
regulated by antibiotic therapy (p = 0.002). (SBP, spontaneous bacterial peritonitis.).
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neutrophil CD64 expression before and after therapy is shown
in Figure 7.
4. Discussion
SBP is a frequent and life-threatening bacterial infection in
patients with liver cirrhosis and ascites. Portal hypertension leads
to translocation of the intestinal bacteria, which cannot be
eliminated due to immune defects caused by liver cirrhosis.
However, the positive rate of ascites culture in SBP in the
laboratory is extremely low owing to dilution by large amounts
of water. In the samples included in this study, 13 out of 41 had
positive ascites cultures, giving a positive rate of 31.71%. E. coli and
K. pneumoniae were the pathogens most frequently responsible for
infection, which is in agreement with previous studies.20–22
On account of the low positive rate of ascites culture, the
diagnosis of SBP is based on a PMN count 0.25  109 cells/l in
ascites clinically. However, an invasive test – paracentesis – is
required to obtain the PMN count in ascites; this can be dangerous
and is not always readily available for antibiotic therapy.
Therefore, efforts must be made to develop a rapid and reliable
detection method for the auxiliary diagnosis of SBP.
CD64 is one of the receptors for the Fc portion of immunoglob-
ulin G (IgG) and is also called Fcg receptor I. Many studies have
conﬁrmed that the neutrophil CD64 index can be used to diagnose
bacterial infections in blood with high sensitivity and speciﬁcity,23
and to distinguish bacterial infections from active autoimmune
inﬂammation.24
In this study, it was found that the neutrophil CD64 index can
discriminate between SBP and non-SBP samples. There was a
positive correlation between the neutrophil CD64 index and the
PMN count in ascites. The neutrophil CD64 index could be applied
in the auxiliary diagnosis of SBP. Furthermore, the neutrophil CD64
index at the optimal cut-off value of 2.02 had the best sensitivity
Figure 7. Neutrophil CD64 expression: (A) at ﬁrst diagnosis, and (B) after antibiotic therapy.
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patients. These data demonstrate a similar cut-off value for the
neutrophil CD64 index in diagnosing SBP to that used in the
diagnosis of other diseases. Jukic et al. recommended a CD64 index
value 1.3 for positive infection .25 Motta et al. reported that the
CD64 index was a marker of early-onset sepsis in very low birth
weight neonates with a cut-off value of 2.4 .26 Minar et al. found
that the neutrophil CD64 index cut-off point for newly diagnosed
Crohn’s disease was 1.0.16
The difference in neutrophil CD64 index between culture-
negative SBP patients and culture-positive SBP patients was not
signiﬁcant, thus the index could not be used to distinguish
between microbiologically conﬁrmed and clinically diagnosed
bacterial infections. This is in agreement with a previous analysis
of the clinical value of neutrophil cell surface CD64 expression.27
In the present cohort, the neutrophil CD64 index was
modulated by antibiotic therapy. It was observed that the
neutrophil CD64 index was elevated in SBP patients when ﬁrst
diagnosed with a bacterial infection, but that the increased
neutrophil CD64 index was down-regulated by antibiotic therapy.
Migita et al. reported the same characteristic of neutrophil CD64
expression in familial Mediterranean fever patients.28
Given the dangerous complications that may occur as a result of
diagnostic paracentesis, such as bleeding and infection,7 the rapid
detection and auxiliary diagnosis of SBP with a blood sample is
necessary to improve the survival of cirrhotic patients with ascitic
ﬂuid infections. In the present cirrhotic patients with ascites, a high
speciﬁcity and sensitivity was found for the neutrophil CD64 index
in SBP patients with a time cost of 1–2 h. In this regard, based on its
rapid and cost-effective features, determination of the neutrophil
CD64 index may play an increasingly important role in the rapid
detection and identiﬁcation of SBP, allowing the prompt initiation
of appropriate therapy, which may help to increase the overall
survival of patients at high risk of developing SBP.
In conclusion, the results of this study show that the neutrophil
CD64 index could be used as a sensitive and speciﬁc indicator for
the diagnosis of SBP in cirrhotic patients with ascites. In addition,
the neutrophil CD64 index is modulated by antibiotic therapy and
could be used to evaluate the effect of therapy in SBP patients.
The small number of patients included in this study made it
difﬁcult to deﬁne an accurate cut-off value for the neutrophil CD64
index. Therefore, a larger trial is needed before the neutrophil
CD64 index can be recommended for widespread clinical use.Acknowledgements
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